(Q37179763)

18 August 2017

title

Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding (English)

1 reference

18 August 2017

0 references

1 reference

Ira Berkower

1

1 reference

18 August 2017

Chiraag Patel

2

1 reference

18 August 2017

Yisheng Ni

3

1 reference

18 August 2017

Konstantin Virnik

4

1 reference

18 August 2017

Zhexin Xiang

5

1 reference

18 August 2017

Angelo Spadaccini

6

1 reference

18 August 2017

language of work or name

English

0 references

publication date

2 June 2008

1 reference

18 August 2017

number of pages

9

1 reference

inferred from page(s)

published in

Virology

1 reference

18 August 2017

volume

377

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

330-338

1 reference

Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Identification of a BRCA1-associated kinase with potential biological relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Structure of an unliganded simian immunodeficiency virus gp120 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Antigenic conservation and immunogenicity of the HIV coreceptor binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

All-atom empirical potential for molecular modeling and dynamics studies of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

GP120: target for neutralizing HIV-1 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

On the role of structural information in remote homology detection and sequence alignment: new methods using hybrid sequence profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

The antigenic structure of the HIV gp120 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Advances in Homology Protein Structure Modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Structural definition of a conserved neutralization epitope on HIV-1 gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

7 January 2021

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

7 January 2021

Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

7 January 2021

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.03.040

7 January 2021

10.1016/J.VIROL.2008.03.040

Identifiers

DOI

1 reference

18 August 2017

1 reference